BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16706114)

  • 1. [Detection of MSH2 gene mutation by PCR].
    Zheng D; Liu XP; Li TG; Li J; Tang LJ; Hu WX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):200-3. PubMed ID: 16706114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes.
    Wehner M; Mangold E; Sengteller M; Friedrichs N; Aretz S; Friedl W; Propping P; Pagenstecher C
    Eur J Hum Genet; 2005 Aug; 13(8):983-6. PubMed ID: 15870828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel germline and somatic mutations of the MSH2 gene in hereditary non-polyposis colorectal cancer.
    Ding DC; Huang RL; Chen CH; Chao CF; Chu TY
    Clin Genet; 2007 Feb; 71(2):190-2. PubMed ID: 17250671
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
    Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
    Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer.
    Morak M; Laner A; Scholz M; Madorf T; Holinski-Feder E
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1101-5. PubMed ID: 19047842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
    Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K
    Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 10-Mb paracentric inversion of chromosome arm 2p in activating MSH2 and causing hereditary nonpolyposis colorectal cancer: re-annotation and mutational mechanisms.
    Chen JM
    Genes Chromosomes Cancer; 2008 Jun; 47(6):543-5. PubMed ID: 18335504
    [No Abstract]   [Full Text] [Related]  

  • 8. Origins and prevalence of the American Founder Mutation of MSH2.
    Clendenning M; Baze ME; Sun S; Walsh K; Liyanarachchi S; Fix D; Schunemann V; Comeras I; Deacon M; Lynch JF; Gong G; Thomas BC; Thibodeau SN; Lynch HT; Hampel H; de la Chapelle A
    Cancer Res; 2008 Apr; 68(7):2145-53. PubMed ID: 18381419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
    Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
    Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences.
    Charbonnier F; Baert-Desurmont S; Liang P; Di Fiore F; Martin C; Frerot S; Olschwang S; Wang Q; Buisine MP; Gilbert B; Nilbert M; Lindblom A; Frebourg T
    Hum Mutat; 2005 Sep; 26(3):255-61. PubMed ID: 16086322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer.
    Chan TL; Yuen ST; Kong CK; Chan YW; Chan AS; Ng WF; Tsui WY; Lo MW; Tam WY; Li VS; Leung SY
    Nat Genet; 2006 Oct; 38(10):1178-83. PubMed ID: 16951683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer in an MSH2 gene mutation carrier.
    Westenend PJ; Schütte R; Hoogmans MM; Wagner A; Dinjens WN
    Hum Pathol; 2005 Dec; 36(12):1322-6. PubMed ID: 16311127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene symbol: msh2. Disease: hereditary nonpolyposis colorectal cancer.
    Leonardis D
    Hum Genet; 2006 Jul; 119(6):675. PubMed ID: 17128465
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional analysis of HNPCC-related missense mutations in MSH2.
    Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
    Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
    Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
    Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene symbol: MSH2. Disease: Hereditary nonpolyposis colorectal cancer.
    Otway R; Tetlow N; Hornby J; Doe WF; Kohonen-Corish MR
    Hum Genet; 2005 May; 116(6):536. PubMed ID: 15991307
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene symbol: MSH2. Disease: Hereditary nonpolyposis colorectal cancer.
    Luo DC; Sun MH; Ni YZ; Cai Q; Li XY; Ni SC; Chen ZJ; Zhou H; Ye YH; Ye ZL; Fang Y; Tao CW; Zhang XM
    Hum Genet; 2005 Jul; 117(2-3):298. PubMed ID: 16156026
    [No Abstract]   [Full Text] [Related]  

  • 18. The HNPCC associated MSH2*1906G-->C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population.
    Sun S; Greenwood CM; Thiffault I; Hamel N; Chong G; Foulkes WD
    J Med Genet; 2005 Oct; 42(10):766-8. PubMed ID: 16199548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination.
    Yanaba K; Nakagawa H; Takeda Y; Koyama N; Sugano K
    Br J Dermatol; 2008 Jan; 158(1):150-6. PubMed ID: 17941949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
    Belvederesi L; Bianchi F; Galizia E; Loretelli C; Bracci R; Catalani R; Amati M; Cellerino R
    Hum Mutat; 2008 Nov; 29(11):E296-309. PubMed ID: 18781619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.